DEA publishes guidance on new training requirements for prescribers of controlled substances On March 28, 2023, the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) released recommendations and the U.S. Drug Enforcement Administration (DEA) issued specific guidance on how practitioners can meet the new training requirements for DEA-registered prescribers of controlled substances. The new law requires all prescribers of schedule II – V controlled substances to meet a one-time eight-hour training requirement on identifying, treating, and managing patients with opioid or other substance use disorders. Many California-licensed physicians may have already met the new DEA requirements because California requires similar education. While the California Medical Association (CMA) did not ... April 6, 2023 DEA, Drug Prescribing/Dispensing, General, Healthcare, Mental Health, Patient Care SAMHSA, TRAINING 0 0 Comment Read More »
